株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

前立腺がん治療薬の世界市場 2020年

Prostate Cancer Drugs Global Market Report 2020

発行 The Business Research Company 商品コード 918135
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
前立腺がん治療薬の世界市場 2020年 Prostate Cancer Drugs Global Market Report 2020
出版日: 2019年12月09日 ページ情報: 英文
概要

当レポートでは、世界の前立腺がん治療薬市場を調査し、市場の概要、タイプ・治療薬・エンドユーザー・地域・国別の市場規模の推移と予測、市場シェア、成長率、市場の成長要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 前立腺がん治療薬市場の特徴

  • 市場の定義
  • 主な市場区分

第3章 前立腺がん治療薬の市場規模と成長率

  • 市場規模
  • 市場規模と成長率(実績値)
    • 市場の成長要因
    • 市場の阻害要因
  • 市場規模と成長率(予測値)
    • 市場の成長要因
    • 市場の阻害要因

第4章 前立腺がん治療薬市場の分析:セグメント別

  • 市場区分:タイプ別(実績値・予測値)
    • ホルモン感受性前立腺がん
    • ホルモン不応性前立腺がん
  • 市場区分:治療法別(実績値・予測値)
    • ホルモン療法
    • 化学療法
    • 免疫療法
    • 分子標的療法
  • 市場区分:エンドユーザー別(実績値・予測値)
    • 病院薬局
    • 小売薬局
    • その他

第5章 前立腺がん治療薬市場の分析:地域・国別

  • 前立腺がん治療薬市場:地域別(実績値・予測値)
  • 前立腺がん治療薬市場:国別(実績値・予測値)

第6章 アジア太平洋地域の前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第7章 中国の前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第8章 インドの前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第9章 日本の前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第10章 オーストラリアの前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第11章 インドネシアの前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第12章 韓国の前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第13章 西欧の前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第14章 英国の前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第15章 ドイツの前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第16章 フランスの前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第17章 東欧の前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第18章 ロシアの前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第19章 北米の前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第20章 米国の前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第21章 南米の前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第22章 ブラジルの前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第23章 中東の前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第24章 アフリカの前立腺がん治療薬市場

  • 市場概要
  • 市場区分:タイプ別(実績値・予測値)
  • 市場区分:治療法別(実績値・予測値)
  • 市場区分:エンドユーザー別(実績値・予測値)

第25章 競合情勢

  • 競争市場の概要
  • 企業プロファイル
    • アステラス製薬
    • AstraZeneca plc
    • Johnson & Johnson
    • Sanofi S.A
    • Bayer AG

第26章 主な合併・買収事例

第27章 市場動向と戦略

第28章 製品パイプラインの分析

第29章 市場見通しと潜在性の分析

第30章 付録

目次

Prostate Cancer Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global prostate cancer drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the prostate cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Prostate Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Type: Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer 2) By Therapy: Hormonal Therapy, Chemotherapy , Immunotherapy, Targeted Therapy 3) By End User: Hospitals, Clinics, Others

Companies Mentioned: Astellas Inc., AstraZeneca plc, Johnson & Johnson, Sanofi S.A, Bayer AG

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Prostate Cancer Drugs Market Characteristics

3. Prostate Cancer Drugs Market Size And Growth

  • 3.1. Global Prostate Cancer Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Prostate Cancer Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Prostate Cancer Drugs Market Segmentation

  • 4.1. Global Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Hormone Sensitive Prostate Cancer
    • Hormone Refractory Prostate Cancer
  • 4.2. Global Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Hormonal Therapy
    • Chemotherapy
    • Immunotherapy
    • Targeted Therapy
  • 4.3. Global Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Hospitals
    • Clinics
    • Other

5. Prostate Cancer Drugs Market Regional And Country Analysis

  • 5.1. Global Prostate Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Prostate Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Prostate Cancer Drugs Market

  • 6.1. Asia-Pacific Prostate Cancer Drugs Market Overview
  • 6.2. Asia-Pacific Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.4. Asia-Pacific Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Prostate Cancer Drugs Market

  • 7.1. China Prostate Cancer Drugs Market Overview
  • 7.2. China Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.4. China Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Prostate Cancer Drugs Market

  • 8.1. India Prostate Cancer Drugs Market Overview
  • 8.2. India Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.4. India Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Prostate Cancer Drugs Market

  • 9.1. Japan Prostate Cancer Drugs Market Overview
  • 9.2. Japan Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.4. Japan Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Prostate Cancer Drugs Market

  • 10.1. Australia Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.3. Australia Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Prostate Cancer Drugs Market

  • 11.1. Indonesia Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.3. Indonesia Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Prostate Cancer Drugs Market

  • 12.1. South Korea Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.3. South Korea Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Prostate Cancer Drugs Market

  • 13.1. Western Europe Prostate Cancer Drugs Market Overview
  • 13.2. Western Europe Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.4. Western Europe Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Prostate Cancer Drugs Market

  • 14.1. UK Prostate Cancer Drugs Market Overview
  • 14.2. UK Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.4. UK Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Prostate Cancer Drugs Market

  • 15.1. Germany Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.3. Germany Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Prostate Cancer Drugs Market

  • 16.5. France Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.6. France Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.7. France Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Prostate Cancer Drugs Market

  • 17.1. Eastern Europe Prostate Cancer Drugs Market Overview
  • 17.2. Eastern Europe Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.4. Eastern Europe Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Prostate Cancer Drugs Market

  • 18.1. Russia Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.3. Russia Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Prostate Cancer Drugs Market

  • 19.1. North America Prostate Cancer Drugs Market Overview
  • 19.2. North America Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.4. North America Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Prostate Cancer Drugs Market

  • 20.1. USA Prostate Cancer Drugs Market Overview
  • 20.2. USA Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.4. USA Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Prostate Cancer Drugs Market

  • 21.1. South America Prostate Cancer Drugs Market Overview
  • 21.2. South America Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.4. South America Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Prostate Cancer Drugs Market

  • 22.1. Brazil Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.3. Brazil Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Prostate Cancer Drugs Market

  • 23.1. Middle East Prostate Cancer Drugs Market Overview
  • 23.2. Middle East Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.4. Middle East Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Prostate Cancer Drugs Market

  • 24.1. Africa Prostate Cancer Drugs Market Overview
  • 24.2. Africa Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.4. Africa Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Prostate Cancer Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Prostate Cancer Drugs Market Competitive Landscape
  • 25.2. Prostate Cancer Drugs Market Company Profiles
    • 25.2.1. Astellas Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. AstraZeneca plc
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Johnson & Johnson
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Sanofi S.A
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Bayer AG
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Prostate Cancer Drugs Market

27. Prostate Cancer Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Prostate Cancer Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer